Industry news
-
Semaglutide VS Tirzepatide
Semaglutide and Tirzepatide are two new GLP-1-based medications used for the treatment of type 2 diabetes and obesity. Semaglutide has demonstrated superior effects in reducing HbA1c levels and promoting weight loss. Tirzepatide, a novel dual GIP/GLP-1 receptor agonist, has also been approved by ...Read more -
What is Orforglipron?
Orforglipron is a novel type 2 diabetes and weight loss treatment drug under development and is expected to become an oral alternative to injectable drugs. It belongs to the glucagon-like peptide-1 (GLP-1) receptor agonist family and is similar to the commonly used Wegovy (Semaglutide) and Mounja...Read more -
What are the differences between the raw material of semaglutide with 99% purity and that with 98% purity?
The purity of Semaglutide is critical to both its efficacy and safety. The main difference between Semaglutide API with 99% purity and 98% purity lies in the amount of active ingredient present and the potential level of impurities in the substance. The higher the purity, the greater the proporti...Read more -
What should I do if I don’t lose weight after using GLP-1 drugs?
What to do if you don’t lose weight on a GLP-1 medication? Importantly, patience is essential when taking a GLP-1 medication like semaglutide. Ideally, it takes at least 12 weeks to see results. However, if you don’t see weight loss by then or have concerns, here are some options to consider. Tal...Read more -
Tirzepatide: The guardian of cardiovascular health
Cardiovascular disease is one of the leading global health threats, and the emergence of Tirzepatide brings new hope for the prevention and treatment of cardiovascular conditions. This medication works by activating both GIP and GLP-1 receptors, not only effectively cont...Read more -
Insulin Injection
Insulin, commonly known as the “diabetes injection”, exists in everyone’s body. Diabetics do not have enough insulin and need additional insulin, so they need to receive injections. Although it is a type of medicine, if it is injected properly and in the right amount, the “...Read more -
Semaglutide is not just for weight loss
Semaglutide is a glucose-lowering drug developed by Novo Nordisk for the treatment of type 2 diabetes. In June 2021, the FDA approved Semaglutide for marketing as a weight loss drug (trade name Wegovy). The drug is a glucagon-like peptide 1 (GLP-1) receptor agonist that can mimic its effects, red...Read more -
What is Mounjaro(Tirzepatide)?
Mounjaro(Tirzepatide) is a drug for weight loss and maintenance that contains the active substance tirzepatide. Tirzepatide is a long-acting dual GIP and GLP-1 receptor agonist. Both receptors are found in pancreatic alpha and beta endocrine cells, heart, blood vessels, ...Read more -
Tadalafil Application
Tadalafil is a medication used to treat erectile dysfunction and certain symptoms of an enlarged prostate. It works by improving blood flow to the penis, enabling a man to achieve and maintain an erection. Tadalafil belongs to a class of drugs known as phosphodiesterase type 5 (PDE5) inhibitors, ...Read more -
New Products Alert
In order to provide more options to the clients in Cosmetic peptides industry, Gentolex will constantly add new products to the list. High quality with varieties categories, there are totally four different series defined by functions in protecting skins, including Anti-aging & anti-wrinkle, ...Read more -
The research progress of opioid peptides from the approval of Difelikefalin
As early as 2021-08-24, Cara Therapeutics and its business partner Vifor Pharma announced that its first-in-class kappa opioid receptor agonist difelikefalin (KORSUVA™) was approved by the FDA for the treatment of chronic kidney disease (CKD) patients (positive Moderate/severe pruritus with hemod...Read more